Professor Carolyn Taylor
BM BCh (oxon) MA MRCP FRCR DPhil
Professor, Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and professor of oncology. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008.
She now provides clinical leadership in large international collaborations including oncologists, epidemiologists, statisticians and cancer registry staff.
She works in the Early Breast Cancer Trialists’ Collaborative Group on trials of surgery and radiotherapy.
She is Principal Investigator on a Cancer Research UK research program on the benefits and risks of cancer treatments. This programme combines information from high quality datasets to produce estimates of benefits and risks for use by oncologists in the clinic today.
Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials
Taylor CAROLYN. et al, (2023), The Lancet
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009
Duane F. et al, (2022), Clinical and Translational Radiation Oncology
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol